Biote reports third quarter 2023 financial results

Irving, texas--(business wire)--biote (nasdaq: btmd), a leading solutions provider in preventive health care through the delivery of personalized hormone therapy, today announced financial results for the third quarter ended september 30, 2023. third quarter 2023 financial highlights (all financial result comparisons made are against the prior year period) revenue of $45.6 million, an 8.5% increase gross profit margin of 68.9%, a 70-basis point increase net income of $19.6 million, representing.
BTMD Ratings Summary
BTMD Quant Ranking